REGENERON PHARMACEUT

REGN
Real-time Estimate Quote. Real-time Estimate  - 11/23 05:23:26 pm
522.145USD +0.66%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Regeneron Pharmaceuticals specializes in research, development, producing, and selling drugs used in treating ophthalmologic and inflammatory diseases and cancers. Sales break down by activity as follows:
- sales of products (61.5%);
- supply of collaborative services (33.3%): working with Sanofi (54.5% of sales) and Bayer (45.5%);
- sales of technology licenses (5.2%). The group also provides subcontracting research services.
At the end of 2019, the group had a portfolio of 22 products in clinical development.

Number of employees : 8 100 people.
Sales per Business
20182019
USD
(in Million)
%USD
(in Million)
%
Medicines 6,711100% 7,863100%
Sales per region
20182019
USD
(in Million)
%USD
(in Million)
%
United States 4,10661.2% 4,83461.5%
Rest of World 2,66939.8% 2,91637.1%
Managers
Name Title
Leonard S. Schleifer Co-President, Chief Executive Officer & Director
George Damis Yancopoulos Co-President, Director & Chief Scientific Officer
P. Roy Vagelos Chairman
Patrice Gilooly Senior VP-Quality Assurance & Operations
Robert E. Landry Chief Financial Officer & Executive VP-Finance
Neil Stahl Executive VP-Research & Development
Andrew J. Murphy Executive Vice President-Research
Michael S. Brown Independent Director
Joseph L. Goldstein Independent Director
George L. Sing Independent Director
Shareholders
Name Equities %
Fidelity Management & Research Co. LLC 12,079,630 11.6%
The Vanguard Group, Inc. 7,347,976 7.03%
Capital Research & Management Co. (World Investors) 6,644,370 6.36%
SSgA Funds Management, Inc. 4,657,538 4.46%
Wellington Management Co. LLP 3,663,868 3.50%
Capital Research & Management Co. (Global Investors) 3,334,092 3.19%
Loomis, Sayles & Co. LP 3,175,998 3.04%
BlackRock Fund Advisors 2,672,187 2.56%
Icahn Associates Holding LLC 2,444,081 2.34%
The Procter & Gamble Company 2,214,855 2.12%
Company contact information
777 Road Old Saw Mill River
NY 10591 Tarrytown, New York


Phone : +1 (914) 847 7000
Fax :
web site : http://www.regeneron.com
Markets and indexes
-
- Nasdaq Global Select Market
- Nasdaq 100 / S&P 500
Stock Exchange Codes
- Reuters Code :  REGN.O
Sector Bio Therapeutic Drugs
1st jan.Capi. (M$)
REGENERON PHARMACEUTICALS38.15%54 750
GILEAD SCIENCES, INC.-7.49%75 350
VERTEX PHARMACEUTICALS-1.71%55 963
WUXI APPTEC CO., LTD.63.37%35 488
BEIGENE, LTD.71.43%25 903
BIONTECH SE207.17%25 059
GENMAB A/S54.71%23 871
ARGENX SE56.69%12 633
HUALAN BIOLOGICAL ENGINEERING INC.57.18%12 007
MYOKARDIA, INC.208.58%11 993
MIRATI THERAPEUTICS, INC.76.07%11 408
SAREPTA THERAPEUTICS, INC.1.66%10 352
ASCENDIS PHARMA A/S12.49%8 360
NEUROCRINE BIOSCIENCES, INC.-17.20%8 315
ULTRAGENYX PHARMACEUTICAL INC.167.78%7 566
DENALI THERAPEUTICS INC.257.92%7 477
KODIAK SCIENCES INC.94.58%7 058
ARROWHEAD PHARMACEUTICALS, INC.8.47%7 038
ACCELERON PHARMA INC.114.15%6 841
BIOCON LIMITED42.99%6 715
EXELIXIS, INC.7.32%5 867